Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Dual Direct Current Cardioversion Versus Single Direct Current Cardioversion as an Initial Treatment Strategy in Obese Patients

NCT04539158 is registered in ClinicalTrials.gov with Dr. Daniel P Morin, MD MPH FHRS as lead sponsor.

NCT NCT04539158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Dual Direct Current Cardioversion Versus Single Direct Current Cardioversion as an Initial Treatment Strategy in Obese Patients
Lead sponsor
Dr. Daniel P Morin, MD MPH FHRS
Phase
Not applicable
Overall status
Unknown status
Start date
August 7, 2020
Completion date
July 31, 2023
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation